T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$1.15B |
| 2 |
Apple
AAPL
|
+$742M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$647M |
| 4 |
Flowserve
FLS
|
+$577M |
| 5 |
Visa
V
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NWSA
NEWS CORPORATION CL-A
NWSA
|
+$909M |
| 2 |
Union Pacific
UNP
|
+$741M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$580M |
| 4 |
Edwards Lifesciences
EW
|
+$531M |
| 5 |
Accenture
ACN
|
+$474M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.66% |
| 2 | Consumer Discretionary | 13.63% |
| 3 | Financials | 13.54% |
| 4 | Industrials | 11.61% |
| 5 | Technology | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Lexicon Pharmaceuticals
LXRX
$1.05B
| $32.8M | 0.01% |
1,976,007
-84,040
| -4% | -$1.41M |
|
952
TIM SA
TIMB
$8.69B
| $32.8M | 0.01% |
+1,390,000
| New | +$28.1M |
|
|
ATMI
953
DELISTED
A T M I INC
ATMI
| $32.7M | 0.01% |
1,233,262
+47,122
| +4% | +$1.2M |
|
|
SHPG
954
DELISTED
Shire pic
SHPG
| $32.5M | 0.01% |
271,097
-200
| -0.1% | -$22.1K |
|
955
Aaon
AAON
$7.03B
| $32.3M | 0.01% |
2,738,318
+8,638
| +0.3% | +$93.5K |
|
956
Astec Industries
ASTE
$994M
| $32.2M | 0.01% |
895,680
+9,300
| +1% | +$331K |
|
957
AptarGroup
ATR
$8.47B
| $31.9M | 0.01% |
531,060
-8,700
| -2% | -$515K |
|
|
SLXP
958
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $31.8M | 0.01% |
475,873
+4,600
| +1% | +$317K |
|
959
Jabil
JBL
$38.4B
| $31.6M | 0.01% |
1,457,113
-2,234,120
| -61% | -$50.9M |
|
960
M/I Homes
MHO
$3.82B
| $31.6M | 0.01% |
1,531,830
+137,660
| +10% | +$2.89M |
|
961
Sprouts Farmers Market
SFM
$8.03B
| $31.4M | 0.01% |
+707,400
| New | +$28.1M |
|
|
PIKE
962
DELISTED
PIKE CORPORATION COM STK (NC)
PIKE
| $31.3M | 0.01% |
2,764,240
+177,550
| +7% | +$2.11M |
|
|
MJN
963
DELISTED
Mead Johnson Nutrition Company
MJN
| $31.2M | 0.01% |
419,672
+1,910
| +0.5% | +$143K |
|
|
OPTR
964
DELISTED
OPTIMER PHARMACEUTICALS, INC. COM STK
OPTR
| $31.1M | 0.01% |
2,466,300
-2,660,708
| -52% | -$35.3M |
|
|
RFMD
965
DELISTED
RF MICRO DEVICES INC
RFMD
| $31.1M | 0.01% |
5,507,368
+1,883,720
| +52% | +$9.9M |
|
966
Veeco
VECO
$3.26B
| $30.9M | 0.01% |
830,190
-11,400
| -1% | -$399K |
|
|
MIG
967
DELISTED
MEADOWBROOK INSURANCE GRP INC
MIG
| $30.8M | 0.01% |
4,743,663
+875,784
| +23% | +$6.25M |
|
|
ESIO
968
DELISTED
Electro Scientific Industries
ESIO
| $30.8M | 0.01% |
2,629,093
+4,200
| +0.2% | +$48.5K |
|
969
Entegris
ENTG
$24.6B
| $30.7M | 0.01% |
3,025,952
-19,700
| -0.6% | -$191K |
|
970
Constellium
CSTM
$4B
| $30.5M | 0.01% |
1,570,487
+53,120
| +4% | +$966K |
|
|
SFE
971
DELISTED
Safeguard Scientifics, Inc.
SFE
| $30.3M | 0.01% |
1,929,763
+57,166
| +3% | +$880K |
|
|
QEP
972
DELISTED
QEP RESOURCES, INC.
QEP
| $30.2M | 0.01% |
1,091,140
-299,400
| -22% | -$8.66M |
|
|
973
Edwards Lifesciences
EW
$53.6B
| $30.2M | 0.01% |
2,601,570
-45,382,686
| -95% | -$531M |
|
974
FRP Holdings
FRPH
$425M
| $30M | 0.01% |
1,772,216
+3,600
| +0.2% | +$59K |
|
975
Amphenol
APH
$210B
| $29.4M | 0.01% |
3,038,720
-807,840
| -21% | -$7.89M |
|
Similar funds
T. Rowe Price Associates's Q3 2013 Portfolio in Review
As of Q3 2013, T. Rowe Price Associates held 2,531 positions worth $400B, up 7% from $374B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q3 2013 filing shows 100 new, 822 increased, 1,027 reduced and 76 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 36,580,054 shares worth $1.23B. The largest sale was NEWS CORPORATION CL-A, an estimated $909M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 36,580,054 shares worth $1.23B.
- T. Rowe Price Associates added most to Apple in Q3 2013, an estimated $742M increase.
- T. Rowe Price Associates's biggest Q3 2013 reduction was Union Pacific, cutting an estimated $741M.
- T. Rowe Price Associates fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $909M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $400B portfolio in Q3 2013.
- T. Rowe Price Associates opened 100 new positions and closed 76 in Q3 2013.
- T. Rowe Price Associates's portfolio value rose 7% quarter-over-quarter to $400B.
Based on T. Rowe Price Associates's 13F filing for Q3 2013, filed 14 Nov 2013.